Klaria Pharma Holding AB (publ.) (STO:KLAR)
0.8090
+0.0170 (2.15%)
May 26, 2026, 5:29 PM CET
STO:KLAR Revenue
In the year 2025, Klaria Pharma Holding AB (publ.) had annual revenue of 8.99M SEK with 299.69% growth.
Revenue
8.99M
Revenue Growth
+299.69%
P/S Ratio
22.15
Revenue / Employee
2.25M
Employees
4
Market Cap
198.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.99M | 6.74M | 299.69% |
| Dec 31, 2024 | 2.25M | -6.21M | -73.41% |
| Dec 31, 2023 | 8.45M | 2.59M | 44.07% |
| Dec 31, 2022 | 5.87M | -244.00K | -3.99% |
| Dec 31, 2021 | 6.11M | -1.11M | -15.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.66M |
| Cinclus Pharma Holding AB | 67.51M |
| Nanexa AB | 54.32M |
| Enzymatica AB | 53.06M |
| Newbury Pharmaceuticals AB | 32.78M |
| Orexo AB | 17.80M |
| Moberg Pharma AB | 14.59M |
| Enorama Pharma AB | 3.86M |
Klaria Pharma Holding AB (publ.) News
- 3 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q4 2025 - Filings
- 3 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q4 2025 - Filings
- 6 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q3 2025 - Filings
- 6 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q3 2025 - Filings
- 9 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q2 2025 - Filings
- 9 months ago - Klaria Pharma Holding AB (publ.) Quarterly report: Q2 2025 - Filings